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The year 2011 was a satisfactory editorial year for CMI.
Regarding the composition of the editorial board, several
changes were made in order to suit better the evolution
observed within the submissions to the journal. Virology is
now much reinforced with three experts in virology: Guido
Antonelli, Tatjana Avsˇicˇ-Zupanc, and Laurent Kaiser. A new
Associate Editor, Emmanuel Bottieau, from Antwerp in Bel-
gium, was also recently hired to manage submissions in trop-
ical and parasitic diseases, a growing discipline within CMI’s
publication scope. The Scientiﬁc Committee has also
expanded its themes, in order to best assess the various sub-
jects submitted to CMI, and several new experts joined the
Scientiﬁc Committee (Murat Akova, Carl-Erik Nord and
Jesus Rodriguez-Ban˜o for Infectious Diseases, Nick Day and
Nick White for Tropical Diseases, Christian Drosten for
Virology, and Elizabeth Nagy for Bacteriology). In terms of
publications, thematic coverage has consequently evolved
(Table 1; Fig. 1). The works that the journal was initially
receiving were mostly focused on bacteriology, physiopathol-
ogy, and resistance to antibiotics. We now also receive sig-
niﬁcant proportions of manuscripts in clinical virology and in
mycology, and we are receiving an increasing number of sub-
missions regarding tropical and travel diseases. Through this
evolution, CMI reﬂects better the ﬁelds of action of the ESC-
MID, which owns the publication.
The Journal’s Editorial Structure
Each print issue of the journal includes a themed section.
These are organized by a guest editor, and cover key topics.
These consist of three to ﬁve invited reviews on the chosen
topic, an editorial, and related covers. Table 2 presents all
thematic sections published in 2011.
These themed sections are also intended to highlight the
ﬁelds and topics that we wish to publish on. It is thus notice-
able that we recently focused on virology, tropical medicine,
and parasitology. Three themed sections published in 2011 on
tropical diseases, associated with the recruitment of an Asso-
ciate Editor and three members of the Scientiﬁc Committee,
should notably point out to the researchers focusing on these
areas that we are very open to tropical and travel diseases.
Submissions
The proportion of manuscripts submitted as original articles
or as research notes (separated from invited reviews and edi-
torials) is permanently increasing. Also, these manuscripts
come from a large variety of countries (Table 3); this shows
that the journal is sought by many authors in various coun-
tries, even though all countries’ acceptance rates are not cur-
rently equivalent. As compared with 2010, it is interesting to
note that several countries have managed to publish for the
ﬁrst time in CMI, such as Romania, Burkina Faso, and Kuwait
(see Table 3, in bold). This clearly indicates the will of the
journal to be open to the world, including emerging countries.
It is also interesting to note that China and Taiwan are,
respectively, the third and the ﬁfth countries to submit to
CMI. Some articles can involve cultural and organizational dif-
ﬁculties besides their high scientiﬁc quality. This has led sev-
eral times to the journal making efforts to help articles reach
a structure more consistent with the community’s standards.
Online Publications and Backlog
Management
The number of submitted papers is increasing; therefore, the
number of quality papers that we want to publish is also
increasing. This led us to rethink the size and shape of the
journal. In 2010 and 2011, the number of articles in print
increased signiﬁcantly (Table 4). This happened because
there were too many articles waiting to be published (back-
log). We thus decided to clear this backlog of articles by
provisionally increasing the size of the journal. However, in
order to keep both the journal’s volume and the delays
before publication reasonable, we have to maintain a backlog
of a maximum two issues worth of articles (approximately
50). Therefore, along with a higher rejection rate (Table 5;
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Fig. 2), the adopted solution was to publish in print the
reviews and the original articles only, and to systematically
publish only online the research notes and the original arti-
cles having a justiﬁed oversize (exceeding 2500 words). The
online publications have the same citation rates and the same
accessibility; therefore, the authors are not penalized. This
new policy was implemented from August 2011.
Infection Hot Topics
We thought that it was important to appeal for feedback
and reactions, from the editorial staff or from guests, on
urgent topics that seem particularly interesting, and to
publish these quickly. This selection was immediately very
successful, as the second most downloaded paper was a very
early Infection Hot Topic [1] (Table 6).
TABLE 1. Evolution of topics covered by CMI between 2010
and 2011 (publication ratios)
Ratio 2010 (%) Ratio 2011 (%)
Bacteriology 42.4 34.4
Epidemiology 14.4 10.1
Infectious Diseases 17.7 21.2
Mycology 10.3 7.7
Virology 15.2 19.3
Tropical and Parasitic Diseases 0.0 7.4
2010 2011
Bacteriology
Epidemiology
InfecƟous Diseases
Mycology
Virology
Tropical and 
ParasiƟc Diseases
FIG. 1. The evolution of CMI’s thematic coverage between 2010
and 2011.
TABLE 2. Theme sections published in CMI in 2011
CMI 2011 themed sections
Issue Guest editor Topic
January N. Petrosillo Pulmonary vascular disease and infection
February J. M. Pawlotsky Hepatitis C virus: from discovery to
eradication in 40 years?
March G. Pappas Of mice and men: deﬁning, categorizing and
understanding the signiﬁcance of zoonotic
infections
April S. Cutler Spirochaetes: past lessons to future directions
May G. Lina Present and future automation in bacteriology
June M. Drancourt Tuberculosis: an unpredictable long-standing
human companion still in need of rapid
diagnostic tests
July P. Parola Neglected and emerging diseases in
sub-Saharan Africa
August P. Tassios Correlation between genetic resistance and
clinical effect of antibiotics
September G. Greub Infection and pregnancy
October P. Bastien Recent trends in leishmaniases
November M. Paul Control of malaria
December G. Antonelli Viral infections following monoclonal antibodies
TABLE 3. Submissions and acceptance rates by country in
2011
Number
of submissions
Number of
accepted
manuscripts
Acceptance
ratio (%)
Spain 130 25 19.23
France 98 27 27.55
China 82 8 9.76
Italy 77 20 25.97
Taiwan 61 5 8.20
The Netherlands 58 18 31.03
USA 52 8 15.38
India 41 8 19.51
Germany 39 9 23.08
Greece 33 11 33.33
UK 33 7 21.21
Brazil 30 1 3.33
Turkey 29 1 3.45
Switzerland 27 8 29.63
Portugal 22 3 13.64
Japan 21 4 19.05
Iran, Islamic Republic of 20 0 0.00
Sweden 20 3 15.00
Korea, Republic of 18 0 0.00
Denmark 17 6 35.29
Austria 16 2 12.50
Belgium 16 2 12.50
Australia 13 5 38.46
Poland 11 2 18.18
Finland 10 4 40.00
Hong Kong 10 2 20.00
Israel 10 2 20.00
Argentina 9 2 22.22
Canada 9 1 11.11
Norway 8 2 25.00
Thailand 8 4 50.00
Egypt 7 0 0.00
Singapore 7 1 14.29
Romania 6 2 33.33
Slovenia 6 1 16.67
Croatia 5 0 0.00
Kuwait 5 1 20.00
Hungary 4 1 25.00
Mexico 4 0 0.00
Saudi Arabia 4 0 0.00
Tunisia 4 0 0.00
Belarus 3 0 0.00
Ireland 3 0 0.00
Malaysia 3 0 0.00
Pakistan 3 0 0.00
Russian Federation 3 0 0.00
Czech Republic 2 0 0.00
Ethiopia 2 0 0.00
French Guiana 2 1 50.00
Iceland 2 2 100.00
Latvia 2 0 0.00
Lebanon 2 0 0.00
South Africa 2 1 50.00
Ukraine 2 0 0.00
United Arab Emirates 2 1 50.00
Bulgaria 1 0 0.00
Burkina Faso 1 1 100.00
Chile 1 0 0.00
Colombia 1 0 0.00
Cuba 1 0 0.00
Kenya 1 0 0.00
Luxembourg 1 1 100.00
Morocco 1 0 0.00
New Zealand 1 0 0.00
Peru 1 0 0.00
Senegal 1 1 100.00
Serbia 1 0 0.00
Sri Lanka 1 0 0.00
Total 1126 214
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The Position of the Journal within
International Competition
CMI’s position within the international competition is
improving. Its impact factor and its Eigenfactor are progress-
ing in the ﬁelds of both infectious diseases and clinical micro-
biology (Fig. 3). According to these two criteria, CMI
appears to be within the best journals of infectious diseases
and of microbiology. Although these parameters must be
interpreted with prudence, these are signs of good health
for the journal.
Future Evolution and Perspectives
For the next 2 years, we want to keep the journal at its
current size, in order to assess its real impact in the sci-
entiﬁc community. The journal will continue to have a
themed section per issue, as well as around ten original
articles, on top of which research notes and longer arti-
cles will be available online. Also, the journal publishes
supplementary issues (Table 7) that reﬂect congresses
organized by the ESCMID (ECCMID), or conferences
sponsored by partners; these supplements also enjoy a
relatively large number of citations. The supplementary
issues have been managed by the Editorial Board since
2010. Table 5 lists the supplementary issues that were
published in 2011.
TABLE 4. Year-by-year production summary
Year Volume(s) No. of issues No. of pages No. of articles
Average number of days from receipt
at Wiley-Blackwell to:
Online publication Print publication
2012 1 12 1200 228 91a 112a
2011 1 12 1912b 349b 159c 170c
2010 1 12 1798b 319b 101 217
2009 1 12 1194 200 82 90
2008 1 12 1200 206 58 66
2007 1 12 1244 232 80 88
2006 1 12 1266 242 83 91
aPrediction based on current workﬂow.
bIncrease due to clearance of backlog.
cDetailed in Fig. 4—CMI production workﬂow 2011.
TABLE 5. Acceptance and rejection rates for original arti-
cles and research notes: evolution since 2008
Decisioned Accepted Acceptance
rate (%)
Rejected Rejection
rate (%)
2008 826 240 29.0 586 71.0
2009 779 208 26.7 571 73.3
2010 995 239 24.0 756 76.0
2011 1138 214 18.8 924 81.2
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FIG. 2. Acceptance and rejection rates for original articles and
research notes: evolution since 2008.
TABLE 6. Most downloaded articles in 2011
Author(s) Article title Article Type Volume
Full text
access Ref.
Falagas and Kasiskou Mesh-related infections after hernia repair surgery Review 11 4912 [2]
Rolain et al. New Delhi metallo-b-lactamase (NDM-1): towards a new pandemia? Infection Hot Topic 16 4047 [1]
Magiorakos et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant
bacteria: an international expert proposal for interim standard
deﬁnitions for acquired resistance
Original Article 18 3954 [3]
Hill et al. Toxoplasma gondii: transmission, diagnosis and prevention Update 8 3063 [4]
Woo et al. Then and now: use of 16S rDNA gene sequencing for bacterial
identiﬁcation and discovery of novel bacteria in clinical microbiology
laboratories
Review 14 3008 [5]
Leclercq et al. EUCAST expert rules in antimicrobial susceptibility testing Review EV 2803 [6]
Cunha The diagnostic signiﬁcance of relative bradycardia in infectious disease Review 6 2783 [7]
Mackay Real-time PCR in the microbiology laboratory Review 10 2283 [8]
Deurenberg et al. The molecular evolution of methicillin-resistant Staphylococcus aureus Review 13 2189 [9]
Poirel and Nordmann Carbapenem resistance in Acinetobacter baumannii: mechanisms and
epidemiology
Review 12 1508 [10]
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FIG. 3. Kinetics of the evolution of CMI impact factor and Eigenfactor over 9 years, indicating the term of ofﬁce of the past and present CMI
Editors-in-Chief.
TABLE 7. CMI supplementary issues published in 2011
Author Topic Issue Online date Print Sponsor Ref.
Mayr et al. Anidulafungin for the treatment of invasive
candidiasis
17s1
pp. 1–12
20 January 2011 March 2011 Pﬁzer [11]
Ruiz-Camps et al. Guidelines for the Prevention of Invasive
Mould Disease by Filamentous Fungi by the
Spanish Society of Infectious Diseases and
Clinical Microbiology
17s2
pp. 1–24
8 March 2011 April 2011 ESCMID [12]
Vernet et al. Laboratory-based diagnosis of pneumococcal
pneumonia: state of the art and unmet
needs
17s3
pp. 1–13
4 April 2011 May 2011 Fondation Me´rieux [13]
Abstracts of the 21st ECCMID/27th ICC,
Milan, Italy, 7–10 May 2011
17s4
pp. S1–S895
4 May 2011 May 2011 ESCMID [14]
Kullberg et al. European expert opinion on the
management of invasive candidiasis in
adults
17s5
pp. 1–12
28 August 2011 September 2011 Pﬁzer International
Operations
[15]
Woodhead et al. Guidelines for the management of adult
lower respiratory tract infections
17s6
pp. E1–E59
(short version)
Full and short versions
available online
26 September 2011 November 2011 ESCMID [16]
Huovinen et al. Guidelines for management of acute sore
throat
In press ESCMID [17]
TABLE 8. Most cited papers published in 2010
Rank Author Title Type Month
Vol
(Issue)
Times
cited Ref.
1 Miriagou et al. Acquired carbapenemases in Gram-negative bacterial
pathogens: detection and surveillance issues
Review February 16(2) 52 [18]
2 Carmeli et al. Controlling the spread of carbapenemase-producing
Gram-negatives: therapeutic approach and infection
control
Review February 16(2) 35 [19]
3 Allerberger et al. Listeriosis: a resurgent foodborne infection Review January 16(1) 20 [20]
4 Yang et al. Body site colonization in patients with community-
associated methicillin-resistant Staphylococcus aureus and
other types of S. aureus skin infections
Original Article May 16(5) 17 [21]
5 Wallet et al. Preliminary clinical study using a multiplex real-time PCR
test for the detection of bacterial and fungal DNA
directly in blood
Original Article June 16(6) 16 [22]
6 Casalegno et al. Rhinoviruses delayed the circulation of the pandemic
inﬂuenza A (H1N1) 2009 virus in France
Original Article April 16(4) 13 [23]
7 Duchamp et al. Pandemic A(H1N1)2009 inﬂuenza virus detection by real
time RT-PCR: is viral quantiﬁcation useful?
Original Article April 16(4) 13 [24]
8 Weese Clostridium difﬁcile in food—innocent bystander or serious
threat?
Review January 16(1) 12 [25]
9 Linares et al. Changes in antimicrobial resistance, serotypes and
genotypes in Streptococcus pneumoniae over a 30-year
period
Review May 16(5) 12 [26]
10 Doi et al. Extended-spectrum and CMY-type b-lactamase-producing
Escherichia coli in clinical samples and retail meat from
Pittsburgh, USA and Seville, Spain
Original Article January 16(1) 11 [27]
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TABLE 9. Most cited papers published in 2009
Rank Author Title Type Month
Vol
(Issue)
Times
cited Ref.
1 Brown et al. The Panton–Valentine leukocidin vaccine protects mice against lung
and skin infections caused by Staphylococcus aureus USA300
Original Article February 15(2) 47 [28]
2 Westh et al. Multiplex real-time PCR and blood culture for identiﬁcation of
bloodstream pathogens in patients with suspected sepsis
Original Article June 15(6) 41 [29]
3 Crobach et al. European Society of Clinical Microbiology and Infectious Diseases
(ESCMID): data review and recommendations for diagnosing
Clostridium difﬁcile infection
Review December 15(12) 38 [30]
4 Kopterides et al. Statins for sepsis: a critical and updated review Review April 15(4) 30 [31]
5 Nagy et al. Species identiﬁcation of clinical isolates of Bacteroides by
matrix-assisted laser desorption ionization time-of-ﬂight mass
spectrometry
Original Article August 15(8) 30 [32]
6 Greub Parachlamydia acanthamoebae, an emerging agent of pneumonia Review January 15(1) 29 [33]
7 Leclercq Epidemiological and resistance issues in multidrug-resistant
staphylococci and enterococci
Review March 15(3) 25 [34]
8 Worlitzsch et al. Antibiotic-resistant obligate anaerobes during exacerbations of
cystic ﬁbrosis patients
Original Article May 15(5) 25 [35]
9 De Valk et al. Interlaboratory reproducibility of a microsatellite-based typing
assay for Aspergillus fumigatus through the use of allelic ladders:
proof of concept
Original Article February 15(2) 21 [36]
10 Lee et al. Enzyme-linked immunospot assay for interferon-gamma in the
diagnosis of tuberculous pleurisy
Original Article February 15(2) 21 [37]
TABLE 10. Most cited papers published in 2008
Rank Author Title Type Month
Vol
(Issue)
Times
cited Ref.
1 Canton et al. Prevalence and spread of extended-spectrum b-lactamase-
producing Enterobacteriaceae in Europe
Original Article January 14(s1) 104 [38]
2 Rossolini et al. The spread of CTX-M-type extended-spectrum b-lactamases Original Article January 14(s1) 73 [39]
3 Wulf et al. Prevalence of methicillin-resistant Staphylococcus aureus among
veterinarians: an international study
Original Article January 14(1) 63 [40]
4 Rodriguez-Tudela et al. EUCAST Deﬁnitive Document EDef 7.1: method for the
determination of broth dilution MICs of antifungal agents for
fermentative yeasts
Original Article April 14(4) 61 [41]
5 Richardson and Lass-Florl Changing epidemiology of systemic fungal infections Review May 14(s4) 59 [42]
6 Hawkey et al. Prevalence and clonality of extended-spectrum b-lactamases in
Asia
Original Article January 14(s1) 58 [43]
7 Vonberg et al. Infection control measures to limit the spread of Clostridium
difﬁcile
Review May 14(s5) 53 [44]
8 Wulf and Voss Methicillin-resistant Staphylococcus aureus in livestock
animals—an epidemic waiting to happen?
Editorial June 14(6) 52 [45]
9 Woo et al. Then and now: use of 16S rDNA gene sequencing for
bacterial identiﬁcation and discovery of novel bacteria in
clinical microbiology laboratories
Review October 14(10) 46 [5]
10 Bush Prevalence of Staphylococcus aureus carrying Panton–Valentine
leukocidin genes among isolates from hospitalized patients in
China
Original Article April 14(4) 42 [46]
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The Journal’s Top Cited Articles
The top cited papers (Tables 8–10) show that resistance to
antibiotics continues to play a key role in the number of cita-
tions of the journal. However, other elements are beginning
to emerge, and show the expanding audience of CMI. Con-
currently, we have observed a signiﬁcant increase in online
usage of the journal. Indeed, the number of full text down-
loads has reached 615 822 in 2011, compared to 384 900 in
2010 and 260 685 in 2009.
Workﬂow—Evolution Since 2009
The current processing time for the treatment of manu-
scripts has continued to improve since 2009 (Table 11). In
2011, this averaged 20 days; on average 9 days for the imme-
diate rejection, and 31 days for a decision of acceptance,
revision or rejection after peer-review, which at present
appears reasonable. The average time between ﬁnal accep-
tance and the ﬁrst online publication is 1 week for the ver-
sion edited by the author, and 12 weeks for the version
proofread by the publisher. The article is then published
within 4 months in print, for articles for which print publica-
tion applies (Fig. 4). The aim remains for the print version to
be available within 3–4 months after ﬁnal acceptance. After
an average processing time of 4.6 months between accep-
tance and ﬁnal publication over the last 4 years, this objec-
tive is currently being achieved.
Conclusion
The ambition of CMI is to reﬂect the academic activities of
the ESCMID, and more generally of the world of infectious
diseases and clinical microbiology, as well as to attract the
best publications and reviews within the ﬁeld. The number
of submissions is increasing signiﬁcantly, as is their quality,
and one notable fact is the emergence of several countries
contributing papers of high scientiﬁc quality. The aim is to
provide a both fast and fair peer-review process in order to
quickly spread the research results of the scientiﬁc commu-
nity.
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